Capital Performance Advisors »

Inozyme Pharma shares owned by Capital Performance Advisors

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Capital Performance Advisors from 13F filings

Historical chart of Capital Performance Advisors investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Capital Performance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Capital Performance Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $183 35 5.23

More positions owned by Capital Performance Advisors

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us Targeted Vlu (DFAT)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Dimensional Etf Trust Internatnal Val (DFIV)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Specialized Funds Div App Etf (VIG)
NVIDIA Corporation (NVDA)

View all positions for Capital Performance Advisors

Top funds holding Inozyme Pharma

Adage Capital Partners GP
Pivotal bioVenture Partners Investment Advisor
Sofinnova Ventures
Affinity Asset Advisors
Rock Springs Capital Management
BlackRock
Vanguard Group
NEA Management Company
Eventide Asset Management
Millennium Management
FMR
Samsara BioCapital
Saturn V Capital Management
Sphera Funds Management
Geode Capital Management

View all funds holding Inozyme Pharma